文献速递细胞病理与分子病理胸部病理

超声引导经皮经胸细针穿刺细胞学对外周肺结节形态学诊断与分子评估的充分性:与CT引导的比较

Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology.
PubMed 文献 · Arch Pathol Lab Med · 2019-07-22

该研究纳入40例经超声引导经胸细针穿刺细胞学(FNAC)的外周、胸膜下及椎旁肺结节患者,并与40例CT引导FNAC患者比较。结果显示超声引导组95%样本充分且有代表性,诊断率、穿刺针数及细胞量无显著差异,但操作时间更短(平均13.1分钟 vs 23.6分钟),气胸发生更少(1例 vs 9例),成本更低。

要点

  • 超声引导肺结节FNAC在选定的外周、胸膜下及椎旁结节中样本充分率达95%。
  • 与CT引导相比,超声引导诊断率、穿刺针数和细胞量无显著差异。
  • 超声引导操作更快、气胸更少且成本更低,可作为选定患者的替代选择。

核心结论

  • 超声引导经胸FNAC对选定的肺结节具有较高的临床适用性和诊断效用。

研究设计与样本

  • 研究纳入40例经超声引导经胸FNAC的外周、胸膜下及椎旁肺结节患者,并与40例CT引导肺FNAC患者进行比较。
  • 采用风干Diff-Quik染色涂片进行快速现场评估,另备酒精固定涂片行巴氏染色,细胞块用于免疫细胞化学和分子研究,2例加做流式细胞学评估。

主要发现

  • 超声引导FNAC样本在95%的病例中充分且有代表性。
  • 两组在诊断率、穿刺针数及涂片和细胞块的细胞量方面无显著差异。
  • 超声引导FNAC平均操作时间为13.1分钟,CT引导为23.6分钟,超声引导显著更快。
  • 气胸在超声引导FNAC中发生1例,在CT引导FNAC中发生9例,超声引导显著更安全。
  • 超声引导FNAC的成本低于CT引导FNAC。

临床怎么用

  • 对于选定的外周、胸膜下及椎旁肺结节,可考虑采用超声引导经胸FNAC进行形态学诊断和分子评估。
  • 超声引导FNAC操作时间更短、气胸风险更低且成本更低,可作为CT引导的替代选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT.—: Fine-needle aspiration cytology (FNAC) of pulmonary nodules is usually guided by computed tomography (CT), whereas ultrasonography (US) is generally considered not applicable for such purposes. OBJECTIVE.—: To evaluate the clinical applicability and diagnostic utility of US-guided transthoracic FNAC of peripheral pulmonary nodules. DESIGN.—: Ultrasonography-guided transthoracic FNAC was obtained from 40 selected patients with peripheral, subpleural, and paravertebral pulmonary nodules. Air-dried and Diff-Quik-stained smears were used for rapid on-site evaluation; additional smears were alcohol fixed for Papanicolaou staining. Cell blocks were set up for immunocytochemical and molecular studies; in 2 cases, a flow cytometry evaluation was also performed. The series was compared to 40 CT-guided pulmonary FNAC samples from patients with pleural, peripheral, and paravertebral pulmonary nodules, to evaluate differences in terms of diagnostic rate, time of execution, safety, and cost. RESULTS.—: The US-guided FNAC samples had results that were adequate and representative in 95% of cases. No significant differences were observed between the 2 groups in terms of diagnostic rate, number of passes, and cellularity of both smears and cell blocks. The mean time needed for the execution of US-guided FNAC was 13.1 minutes, whereas the mean time for CT-guided FNAC was 23.6 minutes. Thus, US-guided FNAC was significantly more rapid than CT-guided pulmonary FNAC. Because pneumothorax occurred in 1 individual who underwent US-guided FNAC and in 9 who underwent CT-guided FNAC, we might conclude that US-guided FNAC is a significantly safer procedure. Finally, comparing the costs of both procedures, US-guided FNAC is less expensive. CONCLUSIONS.—: Our experience showed an elevated clinical applicability and diagnostic utility of US-guided transthoracic FNAC for selected pulmonary nodules.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Cozzolino I, Ronchi A, Messina G, et al. Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology. Arch Pathol Lab Med. 2019. PMID: 31329477. doi:10.5858/arpa.2018-0346-OA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。